MedTrace Logo

Caudal Bupivacaine vs Bupivacaine Plus Two Doses of Dexmedetomidine for Postoperative Analgesia in Children

NCT02385435 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 91

Last updated 2015-03-11

No results posted yet for this study

Summary

The aim of this prospective randomized double-blind study was to compare the analgesic efficacy and the side effects of two doses of dexmedetomidine (1 and 2 µg.kg-1) co-administered with bupivacaine with bupivacaine alone for caudal analgesia in children undergoing infra-umbilical surgery.

Conditions

  • Pain, Postoperative

Interventions

DRUG

Bupivacaine

Caudal Bupivacaine 2 mg/kg single shot

DRUG

dexmedetomidine 1μg.kg-1

Caudal dexmedetomidine 1μg.kg-1, single shot

DRUG

dexmedetomidine 2μg.kg-1

Caudal dexmedetomidine 2μg.kg-1, single shot

Sponsors & Collaborators

  • University of Jordan

    lead OTHER

Principal Investigators

  • khaled R Al-zaben · University of Jordan

  • Ibraheem Y Qudaisat · University of Jordan

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
1 Year
Max Age
6 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2014-08-31
Completion
2014-08-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02385435 on ClinicalTrials.gov